IMMUNE REPERTOIRE SEQUENCING MARKET ANALYSIS

Name: Immune Repertoire Sequencing Market Size and Trends
Creator: Coherent Market Insights
License: https://www.coherentmarketinsights.com/privacy-policy
Keywords: Immune Repertoire Sequencing Market, Immune Repertoire Sequencing Market Report, Immune Repertoire Sequencing Industry Report, Immune Repertoire Sequencing Market Size, Immune Repertoire Sequencing Market Share, Immune Repertoire Sequencing Market Analysis, Immune Repertoire Sequencing Market Growth, Immune Repertoire Sequencing Market Trends, Immune Repertoire Sequencing Market Overview, Immune Repertoire Sequencing Market Forecast

Immune Repertoire Sequencing Market, By Product Type (Assay Kits (T-Cell Receptor Kits, and B-Cell Receptor Kits) and Instruments), By Application (Cancer Immunotherapy, Biomarker Discovery, Autoimmune Diseases, Vaccine Development and Efficacy, Transplant Rejection and Tolerance, Infectious Diseases, and Other Applications), By End User (Diagnostic Labs, Biotechnology and Pharmaceutical Companies, Academic and Research Institutes, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Published In : Feb 2019
Code : CMI1517
Pages :200
Formats :
Excel and PDF
Industry : Biotechnology

Immune Repertoire Sequencing MarketSize and Trends

The global immune repertoire sequencing market size was valued at US$ 114.3 million in 2017, and is expected to witness a CAGR of 5.6% over the forecast period (2018 – 2026).

Global Immune Repertoire Sequencing Market Share (%) Analysis, By Product Type, 2017

Source: Coherent Market Insights Analysis (2018)

Global Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2026

Source: Coherent Market Insights Analysis (2018)

Increasing Research & Development and Demand for Genomic and Repertoire Sequencing-based Research is expected to Drive Growth of the Immune Repertoire Sequencing Market

Increasing research and development and launches of novel products by key players are expected to be the major driving force for global immune repertoire sequencing market growth in the near future. For instance, in 2016, ArcherDX, Inc. expanded its product portfolio with the launch of Archer Immunoverse immune repertoire sequencing assays at the American Society of Hematology (ASH). In 2017, ArcherDX, Inc. launched Archer Immunoverse B Cell Receptor (BCR) assays to characterize the human B cell repertoire.

According to a study published by Cold Spring Harbor Laboratory, in 2017, researchers from Stanford University applied immune repertoire sequencing to identify disease-related signatures in the immune systems of patients with systemic sclerosis-related pulmonary hypertension (SSc-PAH), a rare chronic autoimmune disease that affects the connective tissue. Therefore, increasing research on immune repertoire sequencing is expected to create a favorable environment for immune repertoire sequencing market growth in the near future.